v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities:    
Net (loss) income $ (3,076) $ 40,118
Adjustments to reconcile net income (loss) to cash provided by operating activities:    
Unrealized (gain) loss on investments, net (109,997) 70,024
Loss (gain) on derivative instruments, net 118,088 (124,635)
Amortization of investment premiums, net 7,961 14,059
Other amortization and depreciation 496 501
Share-based compensation expense 2,029 4,270
(Increase) decrease in accrued interest receivable (3,845) 828
Increase (decrease) in accrued interest payable 2,189 (17,522)
Change in other assets and liabilities, net (7,482) (4,747)
Net cash provided by (used in) operating activities 6,363 (17,104)
Investing activities:    
Purchases of investments (957,078) 0
Principal payments received on trading securities 120,906 78,131
Principal payments received on available-for-sale investments 59,986 18,874
Principal payments received on mortgage loans held for investment 67 307
Net (payments) receipts on derivative instruments (137,035) 172,784
Increase (decrease) in cash collateral posted by counterparties 4,798 (37,494)
Net cash (used in) provided by investing activities (908,356) 232,602
Financing activities:    
Borrowings under repurchase agreements 22,760,699 12,273,321
Repayments of repurchase agreement borrowings (22,089,096) (12,369,717)
Proceeds from issuance of common stock 239,658 86,806
Payments related to tax withholding for share-based compensation (1,181) (527)
Dividends paid (41,616) (24,916)
Net cash provided by (used in) financing activities 868,464 (35,033)
Net (decrease) increase in cash, including cash posted to counterparties (33,529) 180,465
Cash including cash posted to counterparties at beginning of period 621,539 237,864
Cash including cash posted to counterparties at end of period 588,010 418,329
Supplemental Disclosure of Cash Activity:    
Cash paid for interest $ 75,738 $ 92,239

Source